TCMD250117C17500
- 0.62
- +0.12+24.00%
Tactile Systems Technology Newsroom
Piper Sandler Maintains Tactile Systems Technology(TCMD.US) With Buy Rating, Maintains Target Price $25
Oppenheimer Downgrades Tactile Systems Technology(TCMD.US) to Hold Rating
Piper Sandler Sticks to Their Buy Rating for Tactile Systems Technology (TCMD)
BTIG Downgrades Tactile Systems Technology(TCMD.US) to Hold Rating
Tactile Systems Tech Analyst Ratings
B.Riley Financial Initiates Tactile Systems Technology(TCMD.US) With Buy Rating, Announces Target Price $23
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA), BioMarin Pharmaceutical (BMRN) and Tactile Systems Technology (TCMD)
BTIG Maintains Tactile Systems Technology(TCMD.US) With Buy Rating, Maintains Target Price $16
Oppenheimer Maintains Tactile Systems Technology(TCMD.US) With Buy Rating, Maintains Target Price $20
Piper Sandler Maintains Tactile Systems Technology(TCMD.US) With Buy Rating, Maintains Target Price $25
Tactile Systems Technology (TCMD) Gets a Buy From Piper Sandler
Buy Rating Affirmed for Tactile Systems Technology on Product Innovation and Strong Financial Outlook
Oppenheimer Remains a Buy on Tactile Systems Technology (TCMD)
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Tactile Systems Technology (TCMD) and Danaher (DHR)
Analysts Are Bullish on These Healthcare Stocks: Bicycle Therapeutics (BCYC), Tactile Systems Technology (TCMD)
BTIG Keeps Their Buy Rating on Tactile Systems Technology (TCMD)
Tactile Systems Technology (TCMD) Gets a Buy From BTIG
Oppenheimer Sticks to Its Buy Rating for Tactile Systems Technology (TCMD)
Piper Sandler Cuts Tactile Systems Technology Price Target to $23 From $30, Maintains Overweight Rating
Positive Growth Prospects for Tactile Systems Technology: An Analyst's Buy Rating Amid Airway Clearance Challenges